Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression

Mihaela C. Blendea, David Jacobs, Craig S Stump, Samy I. McFarlane, Cristina Ogrin, Gul Bahtyiar, Samir Stas, Pawan Kumar, Quan Sha, Carlos M. Ferrario, James R. Sowers

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

To evaluate the role of renin-angiotensin system (RAS)-mediated oxidative stress in insulin resistance (IR), we compared the effects of the angiotensin II (ANG II) receptor blocker (ARB) valsartan and a superoxide dismutase (SOD) mimetic, tempol, on whole body glucose tolerance and soleus muscle insulin-stimulated glucose uptake in transgenic hypertensive TG(mREN-2)27 (Ren-2) rats. Ren-2 rats and Sprague-Dawley (SD) controls were given valsartan (30 mg/kg) or tempol (1 mmol/l) in their drinking water for 21 days. IR was measured by glucose tolerance testing (1 g/kg glucose ip). IR index (AUC glucose x AUCinsulin) was significantly higher in the Ren-2 animals compared with SD controls (30.5 ± 7.0 × 10 6 arbitrary units in Ren-2 vs. 10.2 ± 2.4 × 10 6 in SD, P < 0.01). Both valsartan and tempol treatment normalized Ren-2 IR index. Compared with SD controls (100%), there was a significant increase in superoxide anion production (measured by lucigenin-enhanced chemiluminescence) in soleus muscles of Ren-2 rats (133 ± 15%). However, superoxide production was reduced in both valsartan-and tempol-treated (85 ± 22% and 59 ± 12%', respectively) Ren-2 rats. Insulin (INS)-mediated 2-deoxyglucose (2-DG) uptake (%SD basal levels) was substantially lower in Ren-2 rat soleus muscle compared with SD (Ren-2 + INS = 110 ± 3% vs. SD + INS = 206 ± 12%, P < 0.05). However, Ren-2 rats treated with valsartan or tempol exhibited a significant increase in insulin-mediated 2-DG uptake compared with untreated transgenic animals. Improvements in skeletal muscle insulin-dependent glucose uptake and whole body IR in rats overexpressing ANG II by ARB or SOD mimetic indicate that oxidative stress plays an important role in ANG II-mediated insulin resistance.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume288
Issue number2 51-2
DOIs
StatePublished - Feb 2005
Externally publishedYes

Fingerprint

Valsartan
Oxidative stress
Angiotensin II
Insulin Resistance
Rats
Oxidative Stress
Insulin
Tissue
Glucose
Skeletal Muscle
Deoxyglucose
Superoxides
Superoxide Dismutase
Muscle
Genetically Modified Animals
Angiotensin Receptor Antagonists
Renin-Angiotensin System
Luminescence
Drinking Water
Area Under Curve

Keywords

  • Insulin resistance
  • Superoxide
  • Valsartan

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Biochemistry

Cite this

Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression. / Blendea, Mihaela C.; Jacobs, David; Stump, Craig S; McFarlane, Samy I.; Ogrin, Cristina; Bahtyiar, Gul; Stas, Samir; Kumar, Pawan; Sha, Quan; Ferrario, Carlos M.; Sowers, James R.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 288, No. 2 51-2, 02.2005.

Research output: Contribution to journalArticle

Blendea, Mihaela C. ; Jacobs, David ; Stump, Craig S ; McFarlane, Samy I. ; Ogrin, Cristina ; Bahtyiar, Gul ; Stas, Samir ; Kumar, Pawan ; Sha, Quan ; Ferrario, Carlos M. ; Sowers, James R. / Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression. In: American Journal of Physiology - Endocrinology and Metabolism. 2005 ; Vol. 288, No. 2 51-2.
@article{c7b06a0a385f4d23af8673fe70ba988c,
title = "Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression",
abstract = "To evaluate the role of renin-angiotensin system (RAS)-mediated oxidative stress in insulin resistance (IR), we compared the effects of the angiotensin II (ANG II) receptor blocker (ARB) valsartan and a superoxide dismutase (SOD) mimetic, tempol, on whole body glucose tolerance and soleus muscle insulin-stimulated glucose uptake in transgenic hypertensive TG(mREN-2)27 (Ren-2) rats. Ren-2 rats and Sprague-Dawley (SD) controls were given valsartan (30 mg/kg) or tempol (1 mmol/l) in their drinking water for 21 days. IR was measured by glucose tolerance testing (1 g/kg glucose ip). IR index (AUC glucose x AUCinsulin) was significantly higher in the Ren-2 animals compared with SD controls (30.5 ± 7.0 × 10 6 arbitrary units in Ren-2 vs. 10.2 ± 2.4 × 10 6 in SD, P < 0.01). Both valsartan and tempol treatment normalized Ren-2 IR index. Compared with SD controls (100{\%}), there was a significant increase in superoxide anion production (measured by lucigenin-enhanced chemiluminescence) in soleus muscles of Ren-2 rats (133 ± 15{\%}). However, superoxide production was reduced in both valsartan-and tempol-treated (85 ± 22{\%} and 59 ± 12{\%}', respectively) Ren-2 rats. Insulin (INS)-mediated 2-deoxyglucose (2-DG) uptake ({\%}SD basal levels) was substantially lower in Ren-2 rat soleus muscle compared with SD (Ren-2 + INS = 110 ± 3{\%} vs. SD + INS = 206 ± 12{\%}, P < 0.05). However, Ren-2 rats treated with valsartan or tempol exhibited a significant increase in insulin-mediated 2-DG uptake compared with untreated transgenic animals. Improvements in skeletal muscle insulin-dependent glucose uptake and whole body IR in rats overexpressing ANG II by ARB or SOD mimetic indicate that oxidative stress plays an important role in ANG II-mediated insulin resistance.",
keywords = "Insulin resistance, Superoxide, Valsartan",
author = "Blendea, {Mihaela C.} and David Jacobs and Stump, {Craig S} and McFarlane, {Samy I.} and Cristina Ogrin and Gul Bahtyiar and Samir Stas and Pawan Kumar and Quan Sha and Ferrario, {Carlos M.} and Sowers, {James R.}",
year = "2005",
month = "2",
doi = "10.1152/ajpendo.00402.2004",
language = "English (US)",
volume = "288",
journal = "American Journal of Physiology",
issn = "0363-6143",
publisher = "American Physiological Society",
number = "2 51-2",

}

TY - JOUR

T1 - Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression

AU - Blendea, Mihaela C.

AU - Jacobs, David

AU - Stump, Craig S

AU - McFarlane, Samy I.

AU - Ogrin, Cristina

AU - Bahtyiar, Gul

AU - Stas, Samir

AU - Kumar, Pawan

AU - Sha, Quan

AU - Ferrario, Carlos M.

AU - Sowers, James R.

PY - 2005/2

Y1 - 2005/2

N2 - To evaluate the role of renin-angiotensin system (RAS)-mediated oxidative stress in insulin resistance (IR), we compared the effects of the angiotensin II (ANG II) receptor blocker (ARB) valsartan and a superoxide dismutase (SOD) mimetic, tempol, on whole body glucose tolerance and soleus muscle insulin-stimulated glucose uptake in transgenic hypertensive TG(mREN-2)27 (Ren-2) rats. Ren-2 rats and Sprague-Dawley (SD) controls were given valsartan (30 mg/kg) or tempol (1 mmol/l) in their drinking water for 21 days. IR was measured by glucose tolerance testing (1 g/kg glucose ip). IR index (AUC glucose x AUCinsulin) was significantly higher in the Ren-2 animals compared with SD controls (30.5 ± 7.0 × 10 6 arbitrary units in Ren-2 vs. 10.2 ± 2.4 × 10 6 in SD, P < 0.01). Both valsartan and tempol treatment normalized Ren-2 IR index. Compared with SD controls (100%), there was a significant increase in superoxide anion production (measured by lucigenin-enhanced chemiluminescence) in soleus muscles of Ren-2 rats (133 ± 15%). However, superoxide production was reduced in both valsartan-and tempol-treated (85 ± 22% and 59 ± 12%', respectively) Ren-2 rats. Insulin (INS)-mediated 2-deoxyglucose (2-DG) uptake (%SD basal levels) was substantially lower in Ren-2 rat soleus muscle compared with SD (Ren-2 + INS = 110 ± 3% vs. SD + INS = 206 ± 12%, P < 0.05). However, Ren-2 rats treated with valsartan or tempol exhibited a significant increase in insulin-mediated 2-DG uptake compared with untreated transgenic animals. Improvements in skeletal muscle insulin-dependent glucose uptake and whole body IR in rats overexpressing ANG II by ARB or SOD mimetic indicate that oxidative stress plays an important role in ANG II-mediated insulin resistance.

AB - To evaluate the role of renin-angiotensin system (RAS)-mediated oxidative stress in insulin resistance (IR), we compared the effects of the angiotensin II (ANG II) receptor blocker (ARB) valsartan and a superoxide dismutase (SOD) mimetic, tempol, on whole body glucose tolerance and soleus muscle insulin-stimulated glucose uptake in transgenic hypertensive TG(mREN-2)27 (Ren-2) rats. Ren-2 rats and Sprague-Dawley (SD) controls were given valsartan (30 mg/kg) or tempol (1 mmol/l) in their drinking water for 21 days. IR was measured by glucose tolerance testing (1 g/kg glucose ip). IR index (AUC glucose x AUCinsulin) was significantly higher in the Ren-2 animals compared with SD controls (30.5 ± 7.0 × 10 6 arbitrary units in Ren-2 vs. 10.2 ± 2.4 × 10 6 in SD, P < 0.01). Both valsartan and tempol treatment normalized Ren-2 IR index. Compared with SD controls (100%), there was a significant increase in superoxide anion production (measured by lucigenin-enhanced chemiluminescence) in soleus muscles of Ren-2 rats (133 ± 15%). However, superoxide production was reduced in both valsartan-and tempol-treated (85 ± 22% and 59 ± 12%', respectively) Ren-2 rats. Insulin (INS)-mediated 2-deoxyglucose (2-DG) uptake (%SD basal levels) was substantially lower in Ren-2 rat soleus muscle compared with SD (Ren-2 + INS = 110 ± 3% vs. SD + INS = 206 ± 12%, P < 0.05). However, Ren-2 rats treated with valsartan or tempol exhibited a significant increase in insulin-mediated 2-DG uptake compared with untreated transgenic animals. Improvements in skeletal muscle insulin-dependent glucose uptake and whole body IR in rats overexpressing ANG II by ARB or SOD mimetic indicate that oxidative stress plays an important role in ANG II-mediated insulin resistance.

KW - Insulin resistance

KW - Superoxide

KW - Valsartan

UR - http://www.scopus.com/inward/record.url?scp=19944429129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944429129&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00402.2004

DO - 10.1152/ajpendo.00402.2004

M3 - Article

VL - 288

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6143

IS - 2 51-2

ER -